FIELD: medicine; pharmacology.
SUBSTANCE: it is suggested to apply 2-methyl-6-isobornyl phenol, 4-methyl-2.6-diisobornyl phenol or 2-(dibutylamino)methyl-4-methyl-6-isobornyl phenol hydrochloride as agents with hemorheological, antiaggregant and antitrombogenic activity.
EFFECT: limitation of erythrocytes aggregation amplification in model of blood hyperviscosity, expressed antiaggregant activity in case of ADP-induced aggregation of platelets and reduction of thrombus mass compared to control in case of blood flow reduction in artery.
5 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
RETINOPROTECTOR | 2009 |
|
RU2406487C1 |
MEDICATION INCREASING BRAIN BLOOD FLOW | 2007 |
|
RU2351321C1 |
AGENT POSSESSING HEMORGHEOLOGICAL AND ANTIPLATELET ACTIVITY | 2007 |
|
RU2342944C1 |
ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
OSMOTIC DIURETIC POSSESSING ANTITOXIC ACTIVITY IN CASE OF ALIPHATIC ALCOHOL POISONING | 2007 |
|
RU2354390C2 |
HEMORHEOLOGICAL AND ANTI-THROMBOSIS AGENT | 2003 |
|
RU2242221C1 |
Authors
Dates
2009-02-27—Published
2007-04-23—Filed